Oncology Pharmacy News

ISOPP member, Dr. Sandrine von Grünigen obtained a doctoral degree at the University of Geneva (Switzerland) for her thesis on ”Handling of cytotoxic drugs and related waste in low and middle-income countries: A toolkit to promote safe handling practices”. Many ISOPP members contributed to the survey. A summary of her research can be found below.


By Inés Mendoza Acosta, Becaria Grupo GEDEFO SEFH

The Oncology Pharmacy Working Group of the Spanish Society of Hospital Pharmacy (GEDEFO-SEFH) held its 7th Annual Meeting on May 18-19 in Madrid. As every year, this meeting has focused on multidisciplinary patient care and the possibility of sharing experiences with colleagues from all over the country. 


By Nick Duncan, Consultant Haemotology Pharmacist, Queen Elizabeth Hospital, Birmingham, UK

One of the things I love about my job is the variety it contains and the fact that I get to wear a number of different hats as part of my role.  I can be a clinical pharmacist, a prescriber, a teacher, a trainer, a researcher and a manager at different times of the working week and so it is perhaps difficult to describe a “typical” day.  But I will do my best……


By Razeeya Khan, Clinical Pharmacy lecturer, University of the Witwatersrand, South Africa

I am Razeeya Khan, a lecturer in the Clinical Pharmacy division at the University of the Witwatersrand in South Africa. I am passionate about furthering oncology pharmacy education in South Africa, and at Wits University we have made strides to introduce oncology pharmacy into our undergraduate and postgraduate curriculum.


By Cajetan Alumona, the University of Nigeria Teaching Hospital Ituku-Ozalla Enugu Oncology Center

Despite a population of 206,139,590 people and 124,815 new cases of cancer diagnosed every year1, Nigeria’s healthcare system continues to face the challenges of crumbling infrastructure and shortage of cancer healthcare professionals including pharmacists.


The purpose of this collection of papers is to showcase and share learning from those who have had experience of these changes including implementing the use of IT solutions and/or IT science to assist and improve clinical outcomes for patients.

The overarching theme for the research topic is impact of COVID-19 pandemic on cancer care.


Submitted by Lynne Nakashima, Chair, ISOPP Immunotherapy Task Force

The ISOPP Immunotherapy Task Force has been hard at work since the fall of 2020, developing resources to assist oncology pharmacy practitioners in managing the care of patients on immunotherapy.


ISOPP Position Paper on the role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions:

The position paper developed by the Immunotherapy Task Force has been published online ahead of print by JOPP. View the paper on the ISOPP website here.


Hot off the press! The revised ISOPP Standards of Practice has been published.

The revised ISOPP Standards of Practice document has been published in the Journal of Oncology Pharmacy Practice and posted to ISOPP’s website.


ISOPP is participating in a Cancer Patient Supportive Care Masterclass and addressing Pharmacogenomics today, February, 2022, presented by Alexandre Chan, PharmD, MPH, BCPS, BCOP, FCCP, FISOPP, APh and Todd Knepper, PharmD respectively!